Current Affairs - National - Discussion

On December 18, 2019, the World Health Organization launched its first biosimilar medicine to treat breast cancer. The WHO intends to make the expensive, life-saving treatment affordable for women all over the world.WHO launched a biosimilar medicine "Trastuzumab" in order to treat breast cancers. It is an antibody that shows high efficacy in curing early stages of breast cancers. It was included in the WHO Essential Medicines List in 2015.